{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:50:57Z","timestamp":1792810257867,"version":"4.5.0"},"reference-count":33,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND:<\/jats:title>\n                  <jats:p>Trial discontinuation and nonpublication represent potential waste in research resources and lead to compromises in medical evidence. Pediatric trials may be particularly vulnerable to these outcomes given the challenges encountered in conducting trials in children. We aimed to determine the prevalence of discontinuation and nonpublication of randomized clinical trials (RCTs) conducted in pediatric populations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>Retrospective, cross-sectional study of pediatric RCTs registered in ClinicalTrials.gov from 2008 to 2010. Data were collected from the registry and associated publications identified (final search on September 1, 2015).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>Of 559 trials, 104 (19%) were discontinued early, accounting for an estimated 8369 pediatric participants. Difficulty with patient accrual (37%) was the most commonly cited reason for discontinuation. Trials were less likely to be discontinued if they were funded by industry compared with academic institutions (odds ratio [OR] 0.46, 95% confidence interval [CI] 0.27\u20130.77). Of the 455 completed trials, 136 (30%) were not published, representing 69\u2009165 pediatric participants. Forty-two unpublished trials posted results on ClinicalTrials.gov. Trials funded by industry were more than twice as likely to result in nonpublication at 24 and 36 months (OR 2.21, 95% CI 1.35\u20133.64; OR 3.12, 95% CI 1.6\u20136.08, respectively) and had a longer mean time to publication compared with trials sponsored by academia (33 vs 24 months, P &amp;lt; .001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>In this sample of pediatric RCTs, discontinuation and nonpublication were common, with thousands of children exposed to interventions that did not lead to informative or published findings. Trial funding source was an important determinant of these outcomes, with both academic and industry sponsors contributing to inefficiencies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2016-0223","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T09:07:17Z","timestamp":1470301637000},"source":"Crossref","is-referenced-by-count":174,"title":["Discontinuation and Nonpublication of Randomized Clinical Trials Conducted in Children"],"prefix":"10.1542","volume":"138","author":[{"given":"Natalie","family":"Pica","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts;"},{"name":"Boston Combined Residency Program, Boston Children's Hospital and Boston Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Bourgeois","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts;"},{"name":"Division of Emergency Medicine and"},{"name":"Computational Health Informatics Program, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"issue":"11","key":"2021120907161568400_B1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.292.11.1363","article-title":"Clinical trial registration: a statement from the International Committee of Medical Journal Editors.","volume":"292","author":"DeAngelis","year":"2004","journal-title":"JAMA"},{"key":"2021120907161568400_B2","unstructured":"World Health Organization\n          . WHO statement on public disclosure of clinical trial results. International Clinical Trials Registry Platform (ICRTP). 2015. Available at: www.who.int\/ictrp\/results\/reporting\/en\/. Accessed June 6, 2015"},{"key":"2021120907161568400_B3","unstructured":"World Medical Association\n          . WMA Declaration of Helsinki\u2014ethical principles for medical research involving human subjects. 2013. Available at: www.wma.net\/en\/30publications\/10policies\/b3\/. Accessed June 6, 2015"},{"issue":"5868","key":"2021120907161568400_B4","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1126\/science.1153632","article-title":"Medicine. Moving toward transparency of clinical trials.","volume":"319","author":"Zarin","year":"2008","journal-title":"Science"},{"issue":"9","key":"2021120907161568400_B5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jama.2009.1242","article-title":"Comparison of registered and published primary outcomes in randomized controlled trials.","volume":"302","author":"Mathieu","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"2021120907161568400_B6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.7326\/0003-4819-153-3-201008030-00006","article-title":"Outcome reporting among drug trials registered in ClinicalTrials.gov.","volume":"153","author":"Bourgeois","year":"2010","journal-title":"Ann Intern Med"},{"key":"2021120907161568400_B7","unstructured":"US National Institutes of Health\n          . History, policies and laws (ClinicaTrials.gov). 2015. Available at: https:\/\/clinicaltrials.gov\/ct2\/about-site\/history. Accessed June 3, 2015"},{"key":"2021120907161568400_B8","unstructured":"US National Library of Medicine\n          . National Institutes of Health Launches ClinicalTrials.gov Results Database. 2013. Available at: www.nlm.nih.gov\/news\/expanded_clinicaltrials.html. Accessed June 12, 2015"},{"key":"2021120907161568400_B9","unstructured":"ClinicalTrials.gov\n          . Available at: https:\/\/clinicaltrials.gov\/. Accessed June 16, 2015"},{"issue":"2","key":"2021120907161568400_B10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamainternmed.2014.6924","article-title":"Association of cardiovascular trial registration with positive study findings: Epidemiological Study of Randomized Trials (ESORT).","volume":"175","author":"Emdin","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"8","key":"2021120907161568400_B11","doi-asserted-by":"crossref","first-page":"e0132382","DOI":"10.1371\/journal.pone.0132382","article-title":"Likelihood of null effects of large NHLBI clinical trials has increased over time.","volume":"10","author":"Kaplan","year":"2015","journal-title":"PLoS One"},{"key":"2021120907161568400_B12","doi-asserted-by":"crossref","first-page":"g6870","DOI":"10.1136\/bmj.g6870","article-title":"Discontinuation and non-publication of surgical randomised controlled trials: observational study.","volume":"349","author":"Chapman","year":"2014","journal-title":"BMJ"},{"key":"2021120907161568400_B13","doi-asserted-by":"crossref","first-page":"f6104","DOI":"10.1136\/bmj.f6104","article-title":"Non-publication of large randomized clinical trials: cross sectional analysis.","volume":"347","author":"Jones","year":"2013","journal-title":"BMJ"},{"issue":"10","key":"2021120907161568400_B14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jama.2014.1361","article-title":"Prevalence, characteristics, and publication of discontinued randomized trials.","volume":"311","author":"Kasenda","year":"2014","journal-title":"JAMA"},{"key":"2021120907161568400_B15","doi-asserted-by":"crossref","first-page":"g3058","DOI":"10.1136\/bmj.g3058","article-title":"Non-publication and delayed publication of randomized trials on vaccines: survey.","volume":"348","author":"Manzoli","year":"2014","journal-title":"BMJ"},{"issue":"9","key":"2021120907161568400_B16","doi-asserted-by":"crossref","first-page":"e1000144","DOI":"10.1371\/journal.pmed.1000144","article-title":"Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.","volume":"6","author":"Ross","year":"2009","journal-title":"PLoS Med"},{"issue":"5","key":"2021120907161568400_B17","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-2847","article-title":"Clinical research involving children: registration, completeness, and publication.","volume":"129","author":"Shamliyan","year":"2012","journal-title":"Pediatrics"},{"key":"2021120907161568400_B18","unstructured":"Congressional Childhood Cancer Caucus\n          . BPCA and PREA reauthorization. 2011. Available at: http:\/\/childhoodcancer-mccaul.house.gov\/issue\/bpca-and-prea-reauthorization. Accessed July 2, 2015"},{"key":"2021120907161568400_B19","unstructured":"US National Institutes of Health\n          . FDAAA 801 requirements. 2015. Available at: https:\/\/clinicaltrials.gov\/ct2\/manage-recs\/fdaaa. Accessed June 3, 2015"},{"key":"2021120907161568400_B20","unstructured":"US National Institutes of Health\n          . Glossary of common site terms. 2015. Available at: https:\/\/clinicaltrials.gov\/ct2\/about-studies\/glossary. Accessed June 2, 2015, 2015."},{"key":"2021120907161568400_B21","unstructured":"US National Institutes of Health\n          . ClinicalTrials.gov protocol data element definitions. 2015. Available at: http:\/\/prsinfo.clinicaltrials.gov\/definitions.html. Accessed June 2, 2015"},{"issue":"9859","key":"2021120907161568400_B22","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)61899-6","article-title":"GBD 2010: design, definitions, and metrics.","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"issue":"17","key":"2021120907161568400_B23","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1001\/jama.2012.3424","article-title":"Characteristics of clinical trials registered in ClinicalTrials.gov, 2007\u20132010.","volume":"307","author":"Califf","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"2021120907161568400_B24","doi-asserted-by":"crossref","first-page":"e0127242","DOI":"10.1371\/journal.pone.0127242","article-title":"Terminated trials in the ClinicalTrials.gov results database: evaluation of availability of primary outcome data and reasons for termination.","volume":"10","author":"Williams","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"2021120907161568400_B25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJMsa1409364","article-title":"Compliance with results reporting at ClinicalTrials.gov.","volume":"372","author":"Anderson","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"2021120907161568400_B26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1740774514558307","article-title":"Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials.","volume":"12","author":"Carlisle","year":"2015","journal-title":"Clin Trials"},{"issue":"12","key":"2021120907161568400_B27","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/archpediatrics.2009.229","article-title":"Safety and transparency of pediatric drug trials.","volume":"163","author":"Benjamin","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2021120907161568400_B28","volume-title":"Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act","author":"Field","year":"2012"},{"key":"2021120907161568400_B29","doi-asserted-by":"crossref","first-page":"i637","DOI":"10.1136\/bmj.i637","article-title":"Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers.","volume":"352","author":"Chen","year":"2016","journal-title":"BMJ"},{"key":"2021120907161568400_B30","doi-asserted-by":"crossref","first-page":"f3601","DOI":"10.1136\/bmj.f3601","article-title":"Restoring the integrity of the clinical trial evidence base.","volume":"346","author":"Loder","year":"2013","journal-title":"BMJ"},{"key":"2021120907161568400_B31","doi-asserted-by":"crossref","first-page":"f2865","DOI":"10.1136\/bmj.f2865","article-title":"Restoring invisible and abandoned trials: a call for people to publish the findings.","volume":"346","author":"Doshi","year":"2013","journal-title":"BMJ"},{"issue":"5","key":"2021120907161568400_B32","doi-asserted-by":"crossref","first-page":"e004385","DOI":"10.1136\/bmjopen-2013-004385","article-title":"The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer.","volume":"4","author":"Treasure","year":"2014","journal-title":"BMJ Open"},{"key":"2021120907161568400_B33","author":"US National Library of Medicine"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-0223\/1098150\/peds_20160223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-0223\/1098150\/peds_20160223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T01:48:49Z","timestamp":1639100929000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/138\/3\/e20160223\/52736\/Discontinuation-and-Nonpublication-of-Randomized"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,9,1]]},"published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2016-0223","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,1]]},"article-number":"e20160223"}}